"FDA's Lax Rules Foster Revolving Door Culture with Moderna"

An investigation by The BMJ reveals a concerning "revolving door" culture between the US Food and Drug Administration (FDA) and pharmaceutical company Moderna. Two regulators from the FDA's Office of Vaccines Research and Review recently left their positions to work for Moderna, raising questions about conflicts of interest and the integrity of government decision-making. The FDA lacks records on where employees go after leaving government service and does not require approval or clearance before taking up industry jobs. Critics argue for stricter regulations, including a cooling-off period and ethics pledges, to prevent potential abuses of power and ensure public trust in regulatory agencies.